×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [58]
内容类型
期刊论文 [58]
发表日期
2017 [58]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共58条,第1-10条
帮助
限定条件
发表日期:2017
内容类型:期刊论文
专题:山东大学
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
期刊论文
CURRENT MEDICINAL CHEMISTRY, 2017, 卷号: 24, 期号: 6, 页码: 590-613
作者:
Liu, Jingru
;
Ma, Shutao
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/16
ALK
NSCLC
inhibitors
point mutations
biological activity
SAR
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 页码: S3-S3
作者:
Han, Baohui
;
Li, Kai
;
Wang, Qiming
;
Zhao, Yizhuo
;
Zhang, Li
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/16
Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases
期刊论文
慢性疾病与转化医学:英文版, 2017, 期号: 04
作者:
Ling-Ling Kong
;
Lin-Lin Wang
;
Li-Gang Xing
;
Jin-Ming Yu
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/11
Long-term outcomes of stage I NSCLC (<= 3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis
期刊论文
JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 11, 页码: 4561-+
作者:
Qu, Xiao
;
Wang, Kai
;
Zhang, Tiehong
;
Shen, Hongchang
;
Dong, Wei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/11
Segmentectomy
lobectomy
non-small cell lung cancer (NSCLC)
prognosis
lymph nodes (LN)
Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 34, 页码: 56714-56725
作者:
Wei, Zhigang
;
Ye, Xin
;
Yang, Xia
;
Zheng, Aimin
;
Huang, Guanghui
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
epidermal growth factor receptor
tyrosine kinase inhibitors
non-small
cell lung cancer
microwave ablation
progression free survival
Alpha5 Nicotinic Acetylcholine Receptor Contributes to Nicotine-Induced Lung Cancer Development and Progression
期刊论文
FRONTIERS IN PHARMACOLOGY, 2017, 卷号: 8
作者:
Sun, Hai-Ji
;
Jia, Yan-Fei
;
Ma, Xiao-Li
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/11
alpha5 nicotinic acetylcholine receptor
cell cycle
tumor growth
survival time
nicotine
non-small cell lung cancer
Cordycepin induces autophagy-mediated c-FLIPL degradation and leads to apoptosis in human non-small cell lung cancer cells
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 4, 页码: 6691-6699
作者:
Yu, Xinghui
;
Ling, Jianya
;
Liu, Xianfang
;
Guo, Sen
;
Lin, Yidan
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/11
apoptosis
c-FLIP
autophagy
cordycepin
Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed (vol 8, pg 74910, 2017)
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 66, 页码: 110732-110732
作者:
Zhang, Nasha
;
Kong, Li
;
Shi, Fang
;
Jing, Wang
;
Wang, Haiyong
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/11
Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases
期刊论文
慢性疾病与转化医学, 2017, 卷号: 3, 期号: 4, 页码: 221-229
作者:
Kong Lingling
;
Wang Linlin
;
Xing Ligang
;
Yu Jinming
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/11
Non-small cell lung cancer
Brain metastases
Epidermal growth factor receptor mutation
Tyrosine kinase inhibitors
Therapeutic outcomes
Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST) A case report
期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 10
作者:
Ding, Xingchen
;
Wang, Linlin
;
Liu, Xijun
;
Sun, Xindong
;
Yu, Jinming
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
early-stage NSCLC
EGFR-TKI
genetic examination
metachronous second
primary tumor
therapy
©版权所有 ©2017 CSpace - Powered by
CSpace